Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2020

14.03.2020

The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study

verfasst von: Andrea Cheville, Minji Lee, Timothy Moynihan, Kathryn H. Schmitz, Mary Lynch, Fabiola Rios De Choudens, Lorraine Dean, Jeffrey Basford, Terry Therneau

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer treatment–related late effects degrade survivors’ quality of life, independence, and societal integration, yet may be ameliorated, or even reversed, with effective care. Unfortunately, survivors inconsistently receive this care and the impact on their healthcare utilization is unknown. We sought to estimate differences in utilization between breast cancer (BC) survivors with and without upper extremity lymphedema; a common, remediable late effect.

Methods

We conducted a population-based, retrospective longitudinal cohort study of survivors with incident BC diagnosed from January 1, 1990, through December 31, 2010. HC utilization was characterized using the Berenson-Eggers Type of Service (BETOS) categories. Outcomes included overall healthcare utilization as well as its compartmentalization into the BETOS categories of (1) Evaluation and management, (2) Procedures, (3) Imaging, (4) Tests, (5) Durable medical equipment, (6) Physical/occupational therapy, (7) Other, and (8) Exceptions/Unclassified.

Results

The cohort included 1906 subjects of which 94% (1800) had records meeting the inclusion criteria. Mean follow-up per survivor was 12.8 years (mean, 11, range 1–25 years). Analysis revealed that (1) survivors with BC-associated lymphedema used > 30% more services annually; (2) their increased utilization lessened but persisted for at least 10 years after diagnosis; and (3) this finding of increased utilization extends across all BETOS categories, is further amplified as BMI increases, and cannot be explained solely by lymphedema-directed care.

Conclusions

BC-related lymphedema appears to be an important driver of survivors’ healthcare utilization and guideline-concordant activities to reduce its incidence and severity may be cost neutral or saving.

Implications for Cancer Survivors

Early detection and effective management of cancer-related late effects like lymphedema may reduce survivors’ healthcare needs in the decades that follow their cancer treatment.
Literatur
1.
Zurück zum Zitat Guy GP Jr, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749–57.PubMedPubMedCentralCrossRef Guy GP Jr, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31:3749–57.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Guy GP Jr, Yabroff KR, Ekwueme DU, Rim SH, Li R, Richardson LC. Economic burden of chronic conditions among survivors of cancer in the United States. J Clin Oncol. 2017;35:2053–61.PubMedPubMedCentralCrossRef Guy GP Jr, Yabroff KR, Ekwueme DU, Rim SH, Li R, Richardson LC. Economic burden of chronic conditions among survivors of cancer in the United States. J Clin Oncol. 2017;35:2053–61.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Ekwueme DU, Yabroff KR, Guy GP Jr, et al. Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63:505–10.PubMedPubMedCentral Ekwueme DU, Yabroff KR, Guy GP Jr, et al. Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63:505–10.PubMedPubMedCentral
4.
Zurück zum Zitat Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25:1029–36.CrossRef Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25:1029–36.CrossRef
5.
Zurück zum Zitat Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–89.CrossRefPubMed Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–89.CrossRefPubMed
6.
Zurück zum Zitat Fernandez-Pineda I, Hudson MM, Pappo AS, Bishop MW, Klosky JL, Brinkman TM, et al. Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study. J Cancer Surviv. 2017;11:1–12.PubMedCrossRef Fernandez-Pineda I, Hudson MM, Pappo AS, Bishop MW, Klosky JL, Brinkman TM, et al. Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study. J Cancer Surviv. 2017;11:1–12.PubMedCrossRef
7.
Zurück zum Zitat Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SA, Pronk A, van den Bos F. Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol. 2015;6:153–64.PubMedCrossRef Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SA, Pronk A, van den Bos F. Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol. 2015;6:153–64.PubMedCrossRef
8.
Zurück zum Zitat Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118:2237–49.PubMedCrossRef Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118:2237–49.PubMedCrossRef
9.
Zurück zum Zitat Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12:289–94.PubMedCrossRef Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12:289–94.PubMedCrossRef
10.
Zurück zum Zitat Nesvold IL, Fossa SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol. 2010;49:347–53.PubMedCrossRef Nesvold IL, Fossa SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol. 2010;49:347–53.PubMedCrossRef
11.
Zurück zum Zitat Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg. 2018;71:1041–50.PubMedCrossRef Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg. 2018;71:1041–50.PubMedCrossRef
12.
Zurück zum Zitat Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol. 2010;49:166–73.PubMedCrossRef Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol. 2010;49:166–73.PubMedCrossRef
13.
Zurück zum Zitat Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, et al. A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011). Lymphology. 2013;46:27–41.PubMed Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, et al. A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011). Lymphology. 2013;46:27–41.PubMed
14.
Zurück zum Zitat Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007–14.PubMedCrossRef Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007–14.PubMedCrossRef
15.
Zurück zum Zitat Basta MN, Fox JP, Kanchwala SK, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211:133–41.PubMedCrossRef Basta MN, Fox JP, Kanchwala SK, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211:133–41.PubMedCrossRef
16.
Zurück zum Zitat Bar Ad V, Dutta PR, Solin LJ, et al. Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast J. 2012;18:219–25.PubMedCrossRef Bar Ad V, Dutta PR, Solin LJ, et al. Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast J. 2012;18:219–25.PubMedCrossRef
17.
Zurück zum Zitat Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O’Toole JA, et al. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013;140:485–94.PubMedPubMedCentralCrossRef Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O’Toole JA, et al. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013;140:485–94.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd. History of the Rochester epidemiology project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87:1202–13.PubMedPubMedCentralCrossRef Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ 3rd. History of the Rochester epidemiology project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87:1202–13.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41:1614–24.PubMedPubMedCentralCrossRef St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41:1614–24.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173:1059–68.PubMedPubMedCentralCrossRef St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173:1059–68.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Melton LJ 3rd, Hartmann LC, Achenbach SJ, Atkinson EJ, Therneau TM, Khosla S. Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res. 2012;27:1196–205.PubMedPubMedCentralCrossRef Melton LJ 3rd, Hartmann LC, Achenbach SJ, Atkinson EJ, Therneau TM, Khosla S. Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res. 2012;27:1196–205.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Cancer AJCo. Breast. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 347–69. Cancer AJCo. Breast. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 347–69.
23.
Zurück zum Zitat Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13:214–25.PubMedCrossRef Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13:214–25.PubMedCrossRef
24.
Zurück zum Zitat Fleiss J. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76:378–82.CrossRef Fleiss J. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76:378–82.CrossRef
25.
Zurück zum Zitat Norman SA, Miller LT, Erikson HB, Norman MF, McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81:1192–205.PubMedCrossRef Norman SA, Miller LT, Erikson HB, Norman MF, McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81:1192–205.PubMedCrossRef
26.
Zurück zum Zitat Sturgeon KM, Dean LT, Heroux M, Kane J, Bauer T, Palmer E, et al. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. J Cancer Surviv. 2017;11:246–55.PubMedCrossRef Sturgeon KM, Dean LT, Heroux M, Kane J, Bauer T, Palmer E, et al. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. J Cancer Surviv. 2017;11:246–55.PubMedCrossRef
27.
Zurück zum Zitat Beidas RS, Paciotti B, Barg F, Branas AR, Brown JC, Glanz K, et al. A hybrid effectiveness-implementation trial of an evidence-based exercise intervention for breast cancer survivors. J Natl Cancer Inst Monogr. 2014;2014:338–45.PubMedPubMedCentralCrossRef Beidas RS, Paciotti B, Barg F, Branas AR, Brown JC, Glanz K, et al. A hybrid effectiveness-implementation trial of an evidence-based exercise intervention for breast cancer survivors. J Natl Cancer Inst Monogr. 2014;2014:338–45.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.PubMedPubMedCentralCrossRef Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Sagen A, Karesen R, Sandvik L, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol. 2009;48:1111–8.PubMedCrossRef Sagen A, Karesen R, Sandvik L, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol. 2009;48:1111–8.PubMedCrossRef
30.
Zurück zum Zitat Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.PubMedCrossRef Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.PubMedCrossRef
31.
Zurück zum Zitat Togawa K, Ma H, Sullivan-Halley J, et al. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res. 2014;16:414.PubMedPubMedCentralCrossRef Togawa K, Ma H, Sullivan-Halley J, et al. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res. 2014;16:414.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500–15.PubMedCrossRef DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14:500–15.PubMedCrossRef
33.
Zurück zum Zitat Dylke ES, Schembri GP, Bailey DL, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55:1477–83.PubMedCrossRef Dylke ES, Schembri GP, Bailey DL, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55:1477–83.PubMedCrossRef
34.
Zurück zum Zitat Bazemore A, Petterson S, Peterson LE, Phillips RL Jr. More comprehensive care among family physicians is associated with lower costs and fewer hospitalizations. Ann Fam Med. 2015;13:206–13.PubMedPubMedCentralCrossRef Bazemore A, Petterson S, Peterson LE, Phillips RL Jr. More comprehensive care among family physicians is associated with lower costs and fewer hospitalizations. Ann Fam Med. 2015;13:206–13.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Mahr MA, Hayes SN, Shanafelt TD, Sloan JA, Erie JC. Gender differences in physician service provision using Medicare claims data. Mayo Clin Proc. 2017;92:870–80.PubMedCrossRef Mahr MA, Hayes SN, Shanafelt TD, Sloan JA, Erie JC. Gender differences in physician service provision using Medicare claims data. Mayo Clin Proc. 2017;92:870–80.PubMedCrossRef
36.
Zurück zum Zitat Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049–60.PubMedCrossRef Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049–60.PubMedCrossRef
37.
Zurück zum Zitat Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran ME, Berry D, editors. Statistical models in epidemiology: the environment and clinical trials. New York: Springer; 1999. p. 95–134. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran ME, Berry D, editors. Statistical models in epidemiology: the environment and clinical trials. New York: Springer; 1999. p. 95–134.
38.
Zurück zum Zitat Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2017. Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2017.
39.
Zurück zum Zitat Secord AA, Hasselblad V, Von Gruenigen VE, et al. Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2016;140:184–90.PubMedCrossRef Secord AA, Hasselblad V, Von Gruenigen VE, et al. Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol. 2016;140:184–90.PubMedCrossRef
40.
Zurück zum Zitat Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107:djv275.PubMedPubMedCentralCrossRef Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107:djv275.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Hussan H, Gray DM 2nd, Hinton A, Krishna SG, Conwell DL, Stanich PP. Morbid obesity is associated with increased mortality, surgical complications, and incremental health care utilization in the peri-operative period of colorectal cancer surgery. World J Surg. 2016;40:987–94.PubMedCrossRef Hussan H, Gray DM 2nd, Hinton A, Krishna SG, Conwell DL, Stanich PP. Morbid obesity is associated with increased mortality, surgical complications, and incremental health care utilization in the peri-operative period of colorectal cancer surgery. World J Surg. 2016;40:987–94.PubMedCrossRef
42.
Zurück zum Zitat Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92:603–10.PubMedPubMedCentralCrossRef Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92:603–10.PubMedPubMedCentralCrossRef
43.
Metadaten
Titel
The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study
verfasst von
Andrea Cheville
Minji Lee
Timothy Moynihan
Kathryn H. Schmitz
Mary Lynch
Fabiola Rios De Choudens
Lorraine Dean
Jeffrey Basford
Terry Therneau
Publikationsdatum
14.03.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2020
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00851-0

Weitere Artikel der Ausgabe 3/2020

Journal of Cancer Survivorship 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.